Mirabella Financial Services LLP Sells 7,033 Shares of Elevance Health, Inc. $ELV

Mirabella Financial Services LLP cut its stake in shares of Elevance Health, Inc. (NYSE:ELV) by 70.6% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,935 shares of the company’s stock after selling 7,033 shares during the quarter. Mirabella Financial Services LLP’s holdings in Elevance Health were worth $1,147,000 as of its most recent filing with the SEC.

A number of other large investors have also bought and sold shares of the business. WPG Advisers LLC bought a new position in Elevance Health in the 1st quarter valued at $29,000. Vermillion & White Wealth Management Group LLC increased its stake in shares of Elevance Health by 94.9% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 76 shares of the company’s stock valued at $30,000 after buying an additional 37 shares in the last quarter. BOK Financial Private Wealth Inc. bought a new position in shares of Elevance Health in the second quarter valued at about $32,000. Glass Jacobson Investment Advisors llc lifted its position in Elevance Health by 400.0% during the 2nd quarter. Glass Jacobson Investment Advisors llc now owns 100 shares of the company’s stock worth $39,000 after buying an additional 80 shares in the last quarter. Finally, Saudi Central Bank bought a new stake in Elevance Health during the 1st quarter worth about $40,000. 89.24% of the stock is currently owned by institutional investors.

Elevance Health Stock Performance

Shares of NYSE:ELV opened at $333.57 on Friday. Elevance Health, Inc. has a 12-month low of $273.71 and a 12-month high of $458.75. The company’s 50 day moving average price is $333.98 and its two-hundred day moving average price is $334.40. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 0.71. The firm has a market cap of $74.13 billion, a PE ratio of 13.64, a PEG ratio of 1.53 and a beta of 0.52.

Elevance Health (NYSE:ELV) last issued its quarterly earnings results on Tuesday, October 21st. The company reported $6.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.03 by $1.00. The company had revenue of $50.09 billion for the quarter, compared to analyst estimates of $49.26 billion. Elevance Health had a return on equity of 16.17% and a net margin of 2.84%.The company’s revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter last year, the company posted $8.37 EPS. Equities research analysts predict that Elevance Health, Inc. will post 33.96 earnings per share for the current year.

Elevance Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, December 19th. Stockholders of record on Friday, December 5th will be paid a dividend of $1.71 per share. This represents a $6.84 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Friday, December 5th. Elevance Health’s dividend payout ratio (DPR) is presently 27.96%.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Truist Financial set a $400.00 price target on shares of Elevance Health in a report on Tuesday, October 14th. JPMorgan Chase & Co. lifted their price objective on shares of Elevance Health from $384.00 to $394.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 28th. Zacks Research upgraded Elevance Health from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th. Wells Fargo & Company dropped their price objective on shares of Elevance Health from $412.00 to $403.00 and set an “overweight” rating on the stock in a report on Wednesday, October 22nd. Finally, Bank of America upped their price target on Elevance Health from $330.00 to $370.00 and gave the stock a “neutral” rating in a research report on Friday, October 10th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $398.44.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.